IP Library Patent Application 10767106
Patent Application
App. No. 10/767,106

Method and compositions for treatment of acne vulgaris and acne rosacea

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/767,106
Abstract

A topical composition for the treatment of acne vulgaris or acne rosacea comprises an amount of nicotinamide and less than 1% by weight of nicotinic acid. The composition is more effective in the treatment of acne than the same composition would be without the nicotinic acid. A method of treating acne vulgaris or acne rosacea comprises the topical application of a composition comprising nicotinamide and less than 1% by weight of nicotinic acid.

Claims (12)

1 . A method of treating acne vulgaris and acne rosacea comprising applying to the skin of patients afflicted with such disorders a topical composition comprising an amount of nicotinamide combined with less than 1% by weight of nicotinic acid, the resulting formulation being more effective than said amount of nicotinamide by itself.

2 . The method of claim 1 wherein said composition comprises about 1-12% nicotinamide by weight.

3 . The method of claim 2 wherein said composition comprises about 2-10% nicotinamide by weight and about 0.005-0.7% nicotinic acid by weight.

4 . The method of claim 3 wherein said composition comprises about 3-7% nicotinamide by weight and about 0.05-0.2% nicotinic acid by weight.

5 . A method of treating acne vulgaris and acne rosacea comprising adding to the composition of claim 1 other known acne treatment agents.

6 . The method of claim 5 wherein said other known acne treatment agents are selected from the group consisting of clindamycin, erythromycin, retinoic acid, benzoyl peroxide, salicylic acid, azelaic acid, tazarotene, and metronidazole.

7 . A topical composition effective for treating acne vulgaris and acne rosacea comprising a pharmaceutically acceptable carrier and an amount of nicotinamide in combination with less than 1% by weight of nicotinic acid, the resulting formulation being more effective than said amount of nicotinamide by itself.

8 . The composition of claim 7 wherein said composition comprises about 1-12% nicotinamide by weight.

9 . The composition of claim 8 wherein said composition comprises about 2-10% nicotinamide by weight and about 0.005-0.7% nicotinic acid by weight.

10 . The composition of claim 9 wherein said composition comprises about 3-7% nicotinamide by weight and about 0.05-0.2% nicotinic acid by weight.

11 . The composition of claim 7 wherein other known acne treatment agents are included in the composition.

12 . The composition of claim 9 wherein the other known acne treatment agents are selected from the group consisting of clindamycin, erythromycin, retinoic acid, benzoyl peroxide, salicylic acid, azelaic acid, tazarotene, and metronidazole.

Assignments (3)
MERGER Recorded Mar 21, 2006
From: SIRIUS LABORATORIES, INC.
To: DUSA PHARMACEUTICALS, INC.
Reel/Frame 017336/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2004
From: BERNSTEIN, JOEL E.; BERNSTEIN, JOEL E.
To: SIRIUS LABORATORIES
Reel/Frame 014776/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2004
From: BERNSTEIN, JOEL E.
To: SIRIUS LABORATORIES
Reel/Frame 014945/0105 →